Modeling hERG Channel Liability: From Structural Insight to Highly Accurate Qualitative and Quantitative Models
Journal of Chemical Information and Modeling · 2026
DOI: 10.1021/acs.jcim.6c00163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2026. Verfasst von Hongmao Sun und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Center of Advancing Translational Science, The National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland20850, United St…. Hauptthemen laut MEDLINE: Potassium Channel Blockers, Ether-A-Go-Go Potassium Channels, ERG1 Potassium Channel. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural Research Program of the National Institutes of Health (NIH).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Center of Advancing Translational Science, The National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland20850, United States.
ORCID-Profile: Hongmao Sun, Yuhong Wang
Förderung
- Intramural Research Program of the National Institutes of Health (NIH)
Zitieren
APA
Sun, H., Wang, Y., & Shen, M. (2026). Modeling hERG Channel Liability: From Structural Insight to Highly Accurate Qualitative and Quantitative Models. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.6c00163
Vancouver
Sun H, Wang Y, Shen M. Modeling hERG Channel Liability: From Structural Insight to Highly Accurate Qualitative and Quantitative Models. Journal of Chemical Information and Modeling. 2026. doi:10.1021/acs.jcim.6c00163
BibTeX
@article{Sun2026,
author = {Sun, Hongmao and Wang, Yuhong and Shen, Min},
title = {Modeling hERG Channel Liability: From Structural Insight to Highly Accurate Qualitative and Quantitative Models},
journal = {Journal of Chemical Information and Modeling},
year = {2026},
doi = {10.1021/acs.jcim.6c00163}
}
EUVIMED